Cibus, Inc.

NASDAQ:CBUS

Biotechnology

Healthcare
$1.23 +3.10%

+$0.04 today

Market cap
$94.01M
Beta
1.65
P/E (TTM)
-8.6
EPS (TTM)
-$0.16
52W Low $1.09High $4.19

Volume 0.19M

Average 0.51M

Income Statement

Follow revenue through to earnings.

Revenue

$3.64M

FY 2025 · Annual

-14.6% YoY

Operating Income

-$67.46M

FY 2025 · Annual

Net Income

-$127.08M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue25.99M157K1.82M4.26M3.64M
Cost of Revenue28.56M1.53M395K05.92M
Gross Profit(2.57M)(1.38M)1.42M4.26M(2.28M)
Gross Margin-9.9%-877.1%78.3%100.0%-62.8%
Research & Development11.34M11.55M42.37M50.43M44.2M
Selling, General & Admin15.38M9.44M28.91M30.8M26.91M
Operating Expenses26.76M20.99M320.31M262.66M65.18M
Depreciation & Amortization2.34M1.53M4.69M6.86M5.92M
EBITDA(25.43M)(15.21M)(314.59M)(241.64M)(90.77M)
EBITDA Margin-97.9%-9687.9%-17313.4%-5669.5%-2494.3%
Operating Income(29.33M)(22.37M)(318.88M)(258.4M)(67.46M)
Operating Margin-112.9%-14248.4%-17550.0%-6062.8%-1853.9%
Interest Income17K60K527K631K438K
Interest Expense1.43M87K18.89M34.19M35.48M
Other Income / Expenses133K5.48M(18.76M)(24.29M)(64.71M)
Income Before Tax(29.2M)(16.89M)(337.64M)(282.68M)(132.17M)
Pre-Tax Margin-112.4%-10758.6%-18582.4%-6632.7%-3632.1%
Income Tax Expense00(4K)29K29K
Net Income(29.2M)(16.89M)(267.63M)(251.39M)(127.09M)
Net Margin-112.4%-10758.6%-14729.1%-5898.4%-3492.3%
EPS (Basic)(0.05)(0.03)(25.95)(10.83)(2.78)
EPS (Diluted)(0.05)(0.03)(25.95)(10.83)(2.78)
Weighted Avg Shares578.47M578.47M10.31M23.22M457.57M
Weighted Avg Shares (Diluted)578.47M578.47M10.31M23.22M457.57M

CBUS Earnings Waterfall · TTM

NASDAQ:CBUS · Revenue to Net Income

Key Ratios

EPS$-1.77
Gross Margin82.2%
Net Margin-2692.4%
P/E Ratio-5.7
P/S Ratio423.5

Analysis

$4.3M of revenue converted into -$101.4M of net income for the selected period. Gross margin is 82.2% and net margin is -2692.4%, showing how much revenue survives after costs and taxes. EPS is $-1.77, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 13, 2026
4Statement of changes in beneficial ownershipNov 13, 2026
4Statement of changes in beneficial ownershipNov 13, 2026
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026

How much revenue does CBUS generate?

Cibus, Inc. (CBUS) reported $3.64M of revenue in fiscal 2025.

Is CBUS profitable?

Cibus, Inc. (CBUS) reported -$127.08M of net income, with a net margin of -3492.3%.